Materials Healthcare Sector

Cardio Diagnostics Holdings

Market Cap: US$7.0m

Develops and commercializes epigenetics-based clinical tests for cardiovascular disease.

Crescita Therapeutics

Market Cap: CA$9.7m

A dermatology company, provides non-prescription skincare products and prescription drug products in Canada, the United States, and internationally.

Mainz Biomed

Market Cap: US$6.9m

Develops and sells in-vitro diagnostic (IVD) tests for the early detection of cancer in the United States and Europe.

Xylo Technologies

Market Cap: US$6.9m

A technology-based company, provides medical-related devices and products in the United States, Europe, Asia, Israel, and internationally.

Innovative Eyewear

Market Cap: US$6.8m

Engages in the development and sale of smart eyeglasses and sunglasses in North America.

Ontrak

Market Cap: US$6.8m

Operates as a value-based behavioral healthcare company in the United States.

Tenon Medical

Market Cap: US$6.8m

A medical device company, engages in the development of implant for the treatment of severe lower back pain in the United States.

HealthLynked

Market Cap: US$6.8m

A healthcare technology company, operates a cloud-based patient information network and record archiving system in the United States.

PharmaCielo

Market Cap: CA$9.4m

Together with its subsidiary, engages in cultivating, processing, and supplying medicinal-grade cannabis extracts in Canada.

Nymox Pharmaceutical

Market Cap: US$6.7m

A biopharmaceutical company, engages in the research and development of products for the aging population in Canada, the United States, and Europe.

Khiron Life Sciences

Market Cap: CA$9.3m

Operates as an integrated medical and cannabis company in Latin America and Europe.

Cardiogeni

Market Cap: UK£5.0m

A clinical stage biotechnology company, develops heart failure medicines.

Theracryf

Market Cap: UK£5.0m

A clinical stage therapeutics company, engages in the development of therapeutics for oncology and behavioral brain disorders.

National Graphite

Market Cap: US$6.6m

Through its subsidiary, Biotech Development Corp., operates as a biopharmaceutical risk/cost-sharing company.

Universal Ibogaine

Market Cap: CA$9.3m

A life sciences company, develops, acquires, and operates addiction treatment clinics in Canada.

Innovotech

Market Cap: CA$9.2m

Provides assay kits used in growing microbial biofilms for research purposes in Canada, the United States, and internationally.

Nextleaf Solutions

Market Cap: CA$9.2m

A cannabis extraction technology company, engages in the manufacture and distribution of cannabinoid vapes, oils, and softgels in Canada.

Cannabis Bioscience International Holdings

Market Cap: US$6.6m

Cannabis Bioscience International Holdings, Inc.

Eco-Growth Strategies

Market Cap: US$6.5m

Falcon Technologies, Inc. provides various design-build infrastructure services.

Beyond Medical Technologies

Market Cap: US$6.5m

Does not have significant operations.

Algorae Pharmaceuticals

Market Cap: AU$10.1m

A pharmaceutical development company, engages in the research and development of living cells technologies primarily in New Zealand.

Evoke Pharma

Market Cap: US$6.4m

Operates as a specialty pharmaceutical company that focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases.

TransCode Therapeutics

Market Cap: US$6.4m

A biopharmaceutical company, focuses on developing and commercializing drugs and diagnostics for treating and identifying cancer.

AIM ImmunoTech

Market Cap: US$6.4m

An immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States.

Mountain Valley MD Holdings

Market Cap: CA$8.8m

Through its subsidiary, Mountain Valley MD Inc., operates as a health and wellness company in Canada.

Acrux

Market Cap: AU$9.8m

Engages in the development and commercialization of generic and topically applied pharmaceutical products in Australia, Europe, the United States, and internationally.

Cann Group

Market Cap: AU$9.8m

Engages in the breeding, cultivating, manufacturing, and selling medicinal cannabis in Australia and Europe.

Biofrontera

Market Cap: US$6.2m

A biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States.

Impact BioMedical

Market Cap: US$6.2m

Impact BioMedical Inc. discovers, develops, and commercializes products and technologies to address unmet needs in human healthcare and wellness for specialty biopharmaceuticals, antivirals, antimicrobials, consumer healthcare, and wellness products in the United States.

Enzon Pharmaceuticals

Market Cap: US$6.1m

Does not have significant operations.

Telo Genomics

Market Cap: CA$8.5m

A molecular diagnostics company, engages in the development and commercialization of predictive technological products to personalize treatment plans for patients with specific conditions primarily in Canada.

180 Life Sciences

Market Cap: US$6.1m

A clinical stage biotechnology company, focuses on developing therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases in the United States.

Indaptus Therapeutics

Market Cap: US$6.1m

A clinical biotechnology company, develops various anti-cancer and anti-viral immunotherapy products.

SunLink Health Systems

Market Cap: US$6.1m

Through its subsidiaries, provides healthcare products and services in the southeastern United States.

Control Bionics

Market Cap: AU$9.4m

Engages in the research, development, commercialization, and sale of assistive communications technology systems in Australia, North America, and internationally.

Soligenix

Market Cap: US$6.0m

A late-stage biopharmaceutical company, focuses on the development and commercialization of products to treat rare diseases in the United States.